← Lobby register
Disclosed budget
€10,000
Meetings 12mo
0
Policy files
0
Accredited passes
0
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 21 Nov 2024 | Laurent Muschel Acting Director-General | Pipeline presentation | — |
| 21 Nov 2024 | Laurent Muschel Acting Director-General | Pipeline presentation | SRC |
Mission & Goals
ExeVir is a clinical-stage company developing novel antibody therapies that help patients ward off infectious diseases. Our focus is to protect populations unable to benefit from vaccines, such as immunocompromised individuals. The versatile VHH platform enables both prevention and treatment of bacterial and viral threats.
EU Legislative Interests
- EU Strategy on COVID-19 and infectious diseases Therapeutics - A Pharmaceutical Strategy for Europe - Horizon Europe
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Flanders Bio Biovia
Organisation Members
https://flanders.bio/en/member-directory/exevir-bio https://biovia.be/